Results 161 to 170 of about 21,002 (228)

Predicting Deprescribing of High-Risk Medications Using Provider EHR Use and Patient Characteristics

Gu B, Jungo KT, Lauffenburger JC, Choudhry NK, Isaac T, Zambrano J, Yang J.   +6 more
europepmc   +1 more source

Correction: Exploring the Economic Burden of Pulmonary Arterial Hypertension and Its Relation to Disease Severity and Treatment Escalation: A Systematic Literature Review. [PDF]

Pharmacoeconomics
Ramani G, Bali V, Black H, Bond D, Zile I, Humphries AC, Lautsch D.   +6 more
europepmc   +1 more source

Unified Theory of Acceptance and Use of Technology Questionnaire in Swedish Prehospital Care: Translation, Cross-Cultural Adaptation, and Pilot Psychometric Study. [PDF]

JMIR Form Res
Summermatter D, Melin J, Blomberg H, Äng B, Strömsöe A.   +4 more
europepmc   +1 more source

NICE Appraisals of Relugolix-CT and Linzagolix for Endometriosis Symptom Management: Commentary on Clinical and Economic Uncertainties. [PDF]

Pharmacoeconomics
Qendri V, Al M, van Dongen-Leunis A, Krijkamp E, Poley MJ, Mynett ZR, Tian X, Wolff R, Yang H, Armstrong N, Ramos IC.   +10 more
europepmc   +1 more source

Correction: A Framework for Using Cost‑effectiveness Analysis to Support Pricing and Reimbursement Decisions for New Pharmaceuticals in a Context of Evolving Treatments, Prices, and Evidence. [PDF]

Pharmacoeconomics
Woods B, Palacios A, Sculpher M.
europepmc   +1 more source

Patient Out-of-Pocket Spending on Generic and Brand-Name Prescription Drugs.

JAMA Netw Open
Cai CL, Kesselheim AS, Rome BN.
europepmc   +1 more source

A new way to read the price: measuring global affordability of selected NOACs. [PDF]

Front Pharmacol
Cynar J, Cavaco AM, Nowakowska E, Kus K, Ratajczak P, Zaprutko T.   +5 more
europepmc   +1 more source

Subgroup Modelling and Use of External Evidence in Precision Oncology Appraisals: An External Assessment Group Perspective on the NICE Single Technology Appraisal of Zolbetuximab for Untreated CLDN18.2-Positive HER2-Negative Unresectable Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma. [PDF]

Pharmacoeconomics
Scholte M, Fernández Coves A, Yang H, Armstrong N, McDermott K, Tian X, Stirk L, Wolff R, Joore MA, Grimm SE.   +9 more
europepmc   +1 more source

Correction to "The Use of an Automated Insulin Delivery System Is Associated With a Reduction in Diabetes Distress and Improvement in Quality of Life in People With Type 1 Diabetes". [PDF]

Diabetes Obes Metab
europepmc   +1 more source

Cost-Effectiveness and Budget Impact of Lung Cancer Screening: A Systematic Review. [PDF]

Pharmacoeconomics
Chen N, Wang S, Bai J, Franchini F, Winn KM, Hu J, Wang J, Chen G.   +7 more
europepmc   +1 more source